(May 22, 2020, 1:36 PM EDT) -- WILMINGTON, Del. — Drug manufacturer Akorn Inc. on May 20 filed a voluntary petition for reorganization under federal bankruptcy laws, saying it has agreed to an “in-court sale” of its business...
Drug Maker Akorn Seeks Bankruptcy Reorganization, Cites Litigation ‘Overhangs’
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login